238 related articles for article (PubMed ID: 32859745)
1. Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study.
Bozzetti S; Rossini F; Ferrari S; Delogu R; Cantalupo G; Marchioretto F; Zanette G; Zanoni T; Turatti M; Vitale G; Cadaldini M; Rossi F; Di Tizio L; Zuco C; Maniscalco GT; Soldani F; Monaco S; Trinka E; Hoeftberger R; Mariotto S
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1145-1153. PubMed ID: 32859745
[TBL] [Abstract][Full Text] [Related]
2. Utilization of APE2 and RITE2 scores in autoimmune encephalitis patients with seizures.
Rafferty T; Koeppen-Babcock A; Muppidi S; Li Y; Le S
Epilepsy Behav; 2024 May; 154():109737. PubMed ID: 38518672
[TBL] [Abstract][Full Text] [Related]
3. Antibody prevalence and immunotherapy response in Chinese patients with epilepsy and encephalopathy scores for patients with different neuronal surface antibodies.
Jia Y; Wang HF; Zhang MY; Wang YP
Chin Med J (Engl); 2021 Dec; 134(24):2985-2991. PubMed ID: 34882621
[TBL] [Abstract][Full Text] [Related]
4. Predictive models in the diagnosis and treatment of autoimmune epilepsy.
Dubey D; Singh J; Britton JW; Pittock SJ; Flanagan EP; Lennon VA; Tillema JM; Wirrell E; Shin C; So E; Cascino GD; Wingerchuk DM; Hoerth MT; Shih JJ; Nickels KC; McKeon A
Epilepsia; 2017 Jul; 58(7):1181-1189. PubMed ID: 28555833
[TBL] [Abstract][Full Text] [Related]
5. Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology.
Dubey D; Alqallaf A; Hays R; Freeman M; Chen K; Ding K; Agostini M; Vernino S
JAMA Neurol; 2017 Apr; 74(4):397-402. PubMed ID: 28166327
[TBL] [Abstract][Full Text] [Related]
6. KCNA2 IgG autoimmunity in neuropsychiatric diseases.
Arlt FA; Miske R; Machule ML; Broegger Christensen P; Mindorf S; Teegen B; Borowski K; Buthut M; Rößling R; Sánchez-Sendín E; van Hoof S; Cordero-Gómez C; Bünger I; Radbruch H; Kraft A; Ayzenberg I; Klausewitz J; Hansen N; Timäus C; Körtvelyessy P; Postert T; Baur-Seack K; Rost C; Brunkhorst R; Doppler K; Haigis N; Hamann G; Kunze A; Stützer A; Maschke M; Melzer N; Rosenow F; Siebenbrodt K; Stenør C; Dichgans M; Georgakis MK; Fang R; Petzold GC; Görtler M; Zerr I; Wunderlich S; Mihaljevic I; Turko P; Schmidt Ettrup M; Buchholz E; Foverskov Rasmussen H; Nasouti M; Talucci I; Maric HM; Heinemann SH; Endres M; ; Komorowski L; Prüss H
Brain Behav Immun; 2024 Mar; 117():399-411. PubMed ID: 38309639
[TBL] [Abstract][Full Text] [Related]
7. Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study.
Qin X; Yang H; Zhu F; Wang Q; Shan W
Front Immunol; 2021; 12():652864. PubMed ID: 34054814
[TBL] [Abstract][Full Text] [Related]
8. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240
[TBL] [Abstract][Full Text] [Related]
9. Validation of different predictive scoring scales in patients with new-onset epileptic seizures or epilepsy related to neuronal surface antibody-mediated autoimmune encephalitis.
Duan Y; Zhang Z; Zhao X; Cheng H; Zhang S; Guo S; Jin B; Wu X; Aung T
Epilepsy Behav; 2023 Oct; 147():109403. PubMed ID: 37660404
[TBL] [Abstract][Full Text] [Related]
10. Performance of assessment tools in predicting neural autoantibody positivity in patients with seizures.
Peng W; Wang M; Shi W; Wang J; Zhou D; Li J
Int Immunopharmacol; 2024 Mar; 130():111763. PubMed ID: 38412674
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune Epilepsy.
Husari KS; Dubey D
Neurotherapeutics; 2019 Jul; 16(3):685-702. PubMed ID: 31240596
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.
Iorio R; Damato V; Evoli A; Gessi M; Gaudino S; Di Lazzaro V; Spagni G; Sluijs JA; Hol EM
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):138-146. PubMed ID: 28951498
[TBL] [Abstract][Full Text] [Related]
13. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
Caputo D; Iorio R; Vigevano F; Fusco L
Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
[TBL] [Abstract][Full Text] [Related]
14. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis.
Li LH; Ma CC; Zhang HF; Lian YJ
Epilepsy Behav; 2018 Nov; 88():277-282. PubMed ID: 30332659
[TBL] [Abstract][Full Text] [Related]
15. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy.
Toledano M; Britton JW; McKeon A; Shin C; Lennon VA; Quek AM; So E; Worrell GA; Cascino GD; Klein CJ; Lagerlund TD; Wirrell EC; Nickels KC; Pittock SJ
Neurology; 2014 May; 82(18):1578-86. PubMed ID: 24706013
[TBL] [Abstract][Full Text] [Related]
16. Neuronal antibodies in adult patients with new-onset seizures: A prospective study.
Zelano J; Axelsson M; Constantinescu R; Malmeström C; Kumlien E
Brain Behav; 2019 Nov; 9(11):e01442. PubMed ID: 31588654
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease.
Tan TH; Perucca P; O'Brien TJ; Kwan P; Monif M
Epilepsia; 2021 Feb; 62(2):303-324. PubMed ID: 33316111
[TBL] [Abstract][Full Text] [Related]
18. Performance of a pediatric adaptation of the RITE
Panda PK; Ramachandran A; Sharawat IK; Tomar A; Elwadhi A; Kumar V; Bhat NK
Seizure; 2022 Dec; 103():11-17. PubMed ID: 36244182
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated status epilepticus: a retrospective multicenter survey.
Holzer FJ; Rossetti AO; Heritier-Barras AC; Zumsteg D; Roebling R; Huber R; Lerche H; Kiphuth IC; Bardutzky J; Bien CG; Tröger M; Schoch G; Prüss H; Seeck M
Eur Neurol; 2012; 68(5):310-7. PubMed ID: 23051892
[TBL] [Abstract][Full Text] [Related]
20. Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment.
Muñoz-Lopetegi A; de Bruijn MAAM; Boukhrissi S; Bastiaansen AEM; Nagtzaam MMP; Hulsenboom ESP; Boon AJW; Neuteboom RF; de Vries JM; Sillevis Smitt PAE; Schreurs MWJ; Titulaer MJ
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32123047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
